Related references
Note: Only part of the references are listed.Can you hear us now? The impact of health-care utilization by rare disease patients in the United States
Angela A. Navarrete-Opazo et al.
GENETICS IN MEDICINE (2021)
Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database
Stephanie Nguengang Wakap et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2020)
How many rare diseases are there?
Melissa Haendel et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014-2020)
Michael Urbich et al.
PHARMACOECONOMICS (2020)
Genome Sequencing as a Diagnostic Test in Children With Unexplained Medical Complexity
Gregory Costain et al.
JAMA NETWORK OPEN (2020)
A retrospective review of the contribution of rare diseases to paediatric mortality in Ireland
Emer Gunne et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
An integrative knowledge graph for rare diseases, derived from the Genetic and Rare Diseases Information Center (GARD)
Qian Zhu et al.
JOURNAL OF BIOMEDICAL SEMANTICS (2020)
The case for open science: rare diseases
Yaffa R. Rubinstein et al.
JAMIA OPEN (2020)
Genomic sequencing in acutely ill infants: what will it take to demonstrate clinical value?
Scott D. Grosse et al.
GENETICS IN MEDICINE (2019)
A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers
Kym M. Boycott et al.
CELL (2019)
The direct cost of seizure events in severe childhood-onset epilepsies: A retrospective claims-based analysis
Nancy L. Reaven et al.
EPILEPSY & BEHAVIOR (2019)
A new clinical complexity model for the Australian Refined Diagnosis Related Groups
Vera Dimitropoulos et al.
HEALTH POLICY (2019)
Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing
Chloe M. Reuter et al.
JOURNAL OF GENETIC COUNSELING (2019)
Estimating the cost of status epilepticus admissions in the United States of America using ICD-10 codes
Ivan Sanchez Fernandez et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)
Health Care Expenditure Burden of Cancer Care in the United States
Joohyun Park et al.
INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING (2019)
Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations
Lisa B. Feng et al.
HEALTH AFFAIRS (2018)
Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization
Lauge Farnaes et al.
NPJ GENOMIC MEDICINE (2018)
The unsolved rare genetic disease atlas? An analysis of the unexplained phenotypic descriptions in OMIM®
Taila Hartley et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2018)
Impact of biobanks on research outcomes in rare diseases: a systematic review
Monique Garcia et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort
Caroline E. Walker et al.
GENETICS IN MEDICINE (2017)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review
S. Ryder et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Survey of healthcare experiences of Australian adults living with rare diseases
Caron Molster et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Socio-economic burden of rare diseases: A systematic review of cost of illness evidence
Aris Angelis et al.
HEALTH POLICY (2015)
The incidence of urea cycle disorders
Marshall L. Summar et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
Alessandra Biffi et al.
SCIENCE (2013)
Share Paper
